Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Medical oncology · Dongzhimen Hospital · Beijing

Dr. Hou Li侯丽

Chief Physician · Associate Professor
Deputy department head

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

HL

Professional overview

Dr. Hou Li is a Chief Physician and Associate Professor at Dongzhimen Hospital, specializing in integrative medicine for malignant tumors and hematologic disorders.

SpecialtyMedical oncology
Clinical titleChief Physician
Academic rolesAssociate Professor, Master's Supervisor
DepartmentDepartment of Hematology and Oncology
HospitalDongzhimen Hospital
CityBeijing
Hospital roleDeputy Director, Department of Hematology and Oncology

Department leadership

Deputy department head

A department head is an organisational role. “Chief Physician” is a clinical rank; the two are listed separately.

Areas of focus

Integrative treatment of malignant tumorsUsing traditional Chinese medicine combined with conventional oncology to treat lung cancer, gastric cancer, breast cancer, and lymphoma
Reversal of tumor drug resistanceResearch and clinical application focused on reversing tumor resistance to chemotherapy and radiotherapy
Mitigation of chemotherapy and radiotherapy toxicityUsing integrative approaches to reduce adverse effects of chemotherapy and radiotherapy
Palliative care for advanced malignancyProviding symptom control and quality-of-life improvement for patients with advanced tumors
Peri-chemotherapy integrative therapyA conceptual framework developed for integrating traditional Chinese medicine during chemotherapy cycles

Background

  • 2004Published research on traditional Chinese medicine reversal of multidrug resistance in tumors
  • 2005Published studies on dioscin’s effect on breast cancer cell cycle and on uconitine’s mechanism against drug-resistant squamous carcinoma cells
  • 2006Published retrospective clinical study on traditional Chinese medicine use during peri-chemotherapy period in advanced non-small cell lung cancer
  • 2007Published retrospective clinical study on syndrome patterns in advanced non-small cell lung cancer
  • 2011Published research on traditional Chinese medicine intervention for lung cancer angiogenesis and on cancer-related anemia treatment (as corresponding author)

Experience & recognition

  • Participated in over 20 research projects
  • Principal investigator of Beijing Municipal Science and Technology Development Fund project on independent innovation
  • Core member of National Key Technologies R&D Program (Eleventh Five-Year Plan) project on TCM intervention for refractory acute leukemia during peri-chemotherapy
  • Core member of National Natural Science Foundation of China (NSFC) project on cellular and molecular mechanisms of tea polyphenols in inhibiting tumor angiogenesis
  • Core member of Ministry of Science and Technology (MOST) major special project on development of hospital preparation 'Yi Sui Granules'
  • Co-inventor of 2 patents
  • Backbone leader of the State Administration of Traditional Chinese Medicine key discipline 'Traditional Chinese Medicine Internal Medicine Hematology'
  • Recipient of China Association of Integrative Medicine Science and Technology Award (Third Prize) for research on tea polyphenols and tumor angiogenesis
  • Recipient of China Academy of Traditional Chinese Medicine Science and Technology Award (Third Prize) for clinical and basic research on 'Yi Sui Granules' in myelodysplastic syndrome
  • Recipient of Beijing University of Chinese Medicine Science and Technology Award (Third Prize) for research on aconitine’s mechanism against drug-resistant squamous carcinoma cells

Professional roles

  • Member, Beijing Society of Integrative Medicine, Oncology Branch
  • Member, Beijing Anti-Cancer Association, Integrated Traditional Chinese and Western Medicine Branch
  • Editor, Chinese Journal of Clinical Physicians

Frequently asked questions

What does Dr. Hou Li specialize in?

Specializes in integrative treatment of lung cancer, gastric cancer, breast cancer, and lymphoma; reversal of tumor drug resistance; mitigation of chemotherapy and radiotherapy toxicity; palliative care for advanced malignancy; and peri-chemotherapy integrative therapy.

Which hospital and department is Dr. Hou Li in?

Department of Hematology and Oncology at Dongzhimen Hospital

Sources

Dr. Hou Li has not reviewed this page. Request a correction or removal.